Home/Filings/4/0001737840-25-000007
4//SEC Filing

Saia John G. 4

Accession 0001737840-25-000007

CIK 0001576280other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 8:06 PM ET

Size

16.0 KB

Accession

0001737840-25-000007

Insider Transaction Report

Form 4
Period: 2025-10-01
Saia John G.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-01+11,52559,599 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-011,6686,669 total
    Exercise: $0.00Common Stock (1,668 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-01+1,66848,074 total
  • Exercise/Conversion

    Common Stock

    2025-10-01+97446,406 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-019743,896 total
    Exercise: $0.00Common Stock (974 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-0111,52523,401 total
    Exercise: $0.00Common Stock (11,525 underlying)
  • Tax Payment

    Common Stock

    2025-10-01$62.65/sh7,431$465,55252,168 total
Footnotes (5)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1
  • filerCIK 0001737840

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:06 PM ET
Size
16.0 KB